Replies to post #169824 on Avid Bioservices Inc (CDMO)

[BioBS2012]

Doc ... Sounds extremely powerful. How can the company exploit this opportunity ? Why doesn't IR or king explain all this in a PR. Why does it take a message board with several hundred folks reading this technology to support the pps. I'm long and will not sell until the time is right but jeeeez (a little wook) it's not easy to accept the co's lack of enthusiasm and effort. Wouldn't take much IMO.

Mazel, I am sure there will be a PR just prior or during the AACR (April 5-9) when the radiation data is being presented (poster I believe). However, at this stage I do not expect pre-clinical data to move the needle for PPHM (even if the company cried itself hoarse from the roof-top of 1 World Trade Center in NYC. Only possible needle moving events in the short-term (2-6 months duration) are PARTNERSHIP and/or Liver Data - IMO. Even of those two, the PARTNERSHIP would be more heavily weighted IMO.

GLTA